By Susanna Moon
Chicago, April 3 – Citigroup Global Markets Holdings Inc. priced $715,000 of 7.5% single observation Equity LinKed Securities due March 29, 2018 linked to Biogen Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
Interest is payable monthly.
The payout at maturity will be par unless the stock finishes below the trigger level, 80% of the initial share price, in which case the payout will be a number of Biogen shares equal to $1,000 divided by the initial share price or, at the issuer’s option, the cash equivalent.
Citigroup Global Markets Inc. is the underwriter.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Equity LinKed Securities
|
| Underlying stock: | Biogen Inc. (Nasdaq: BIIB)
|
| Amount: | $715,000
|
| Maturity: | March 29, 2018
|
| Coupon: | 7.5%, payable monthly
|
| Price: | Par
|
| Payout at maturity: | If stock falls below trigger level, 3.63875 Biogen shares; otherwise, par in cash
|
| Initial price: | $274.82
|
| Trigger price: | $219.856, 80% of initial level
|
| Pricing date: | March 24
|
| Settlement date: | March 29
|
| Underwriter: | Citigroup Global Markets Inc.
|
| Fees: | 1%
|
| Cusip: | 17324XBJ8
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
